Bernhard O. Boehm,
Professor Bernhard O. Boehm, MD, FRCP, graduated in Medicine from the Johann Wolfgang Goethe-University, Frankfurt am Main, Germany in 1985. He joined the Department of Internal Medicine at Johann Wolfgang Goethe-University Medical Centre in 1985. In 1993 he was appointed as a Full Professor of Internal Medicine at Ulm University and Head of the Division of Diabetes, Endocrinology and Metabolism, Ulm University Medical Centre as well as Director of the College for Nutritionists. From 01/2006 to 12/2008 he acted as the Dean of Studies, Ulm Medical School. Professor Boehm was Vice-President of the International Graduate School in Molecular Medicine of Ulm University from 2004-2013, President of the Research Training Programme “Molecular Diabetology and Endocrinology in Medicine”, and Vice-President of the German Research Council (DFG) funded Programme Project on “Pancreatic Diseases” (1999-2011).
Since 2013 he is Professor of Metabolic Medicine at the Lee Kong Chian School of Medicine, a joined medical school by NTU and Imperial College London. He is Dy-Director of Nanyang Institute of Technology in Medicine (NITHM), NTU, and Senior Consultant, Endocrinology, at the Tan Tock Seng Hospital in Singapore and holds a position as an Associate Faculty Member at the Genome Institute of Singapore, A*STAR, Singapore
Professor Boehm has made seminal contributions in the field of diabetes and metabolic medicine. He has initiated cohort studies defining genetic and epigenetic basis of islet cell autoimmunity. Professor Boehm has also contributed to a better understanding of the basis of micro- and macrovascular complications in diabetic patients. Professor Boehm was Director of a National Institutes of Health (NIH, USA) funded European biobank, which stores samples from more than 1,500 multiplex T1D families. He has published more than 380 papers in internationally peer-reviewed journals. His work has been extensively cited in the scientific literature. In his current studies he is pinpointing the cross-talk between immune cells and insulin-producing ß-cells and the impact of a gene and environmental interplay in the development of metabolic diseases in humans.